Harlan S. Robins, Chief Scientific Officer at Adaptive Biotechnologies Corp (ADPT), sold 106,160 shares at $17.37 ($1.8M) on 2026-06-15, disclosed to the SEC on 2026-06-17.
Scheduled sale ($1.8M) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.37 | 100,000 | $1.7M | 94.0% |
| 2 | $18.01 | 6,160 | $111K | 6.0% |
| Total | $17.41 avg | 106,160 | $1.8M | 100% |
| Filing → |
| ADPT | SELL | 2026-04-10 | $149K | — | Filing → |
| ADPT | SELL | 2026-03-13 | $6.2M | — | Filing → |
| ADPT | SELL | 2026-03-04 | $392K | — | Filing → |